Showing 1 - 10 of 21
Persistent link: https://www.econbiz.de/10014532254
Persistent link: https://www.econbiz.de/10014429097
Using large scale EIB Investment Survey evidence for 2016 covering 8,900 non-financial firms from all size and age classes across all sectors and all EU Member States, we identify different innovation profiles based on a firm's R&D investment and/or innovation activities. We find that "basic"...
Persistent link: https://www.econbiz.de/10011900904
Research and development is seen as a key contributor to growth because it generates knowledge, leading to new or improved products through product innovation, and makes firms more efficient at producing goods through process innovation. Firm- level studies generally find evidence of strong...
Persistent link: https://www.econbiz.de/10013373114
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014468769
Persistent link: https://www.econbiz.de/10014469053
Remedying EU’s deficient overall business R&D performance will require the EU to put more emphasis on nurturing more new firms in new sectors to grow to leading innovator status. It requires addressing the specific barriers faced by these companies, which is first and foremost their access to...
Persistent link: https://www.econbiz.de/10010569209
Remedying EU’s deficient overall business R&D performance will require the EU to put more emphasis on nurturing more new firms in new sectors to grow to leading innovator status. It requires addressing the specific barriers faced by these companies, which is first and foremost their access to...
Persistent link: https://www.econbiz.de/10010570216
Research and development is seen as a key contributor to growth because it generates knowledge, leading to new or improved products through product innovation, and makes firms more efficient at producing goods through process innovation. Firm- level studies generally find evidence of strong...
Persistent link: https://www.econbiz.de/10014278583
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014474941